fbpx

AstraZeneca’s Share Price Reaches A New Resistance Level

$AZN share price reached a new resistance at $60.87 in July 2021, after millions of doses were rolled out across the world. As of yesterday, 40.6% of the world population has received at least one dose of a Covid-19 vaccine. There have been several cases of countries halting the use of the $AZN vaccine as a result of rare cases of blood clots. The share price of major vaccine companies like Moderna, BioNTech-Pfizer, Sinovac had a shortfall. As many companies are making it mandatory for their workers to be vaccinated, more of these vaccines will be rolled out. As many companies are beginning to return to the office, incentives were given to the workers for receiving the Covid-19 jab. Workers who fail to receive the jab might risk termination.

Companies like American Airlines, Bolthouse Farms, Dollar General, Instacart are paying workers after being vaccinated. The price of $AZN went as low as $46.38 in February of this year as several issues were raised across all vaccine manufacturing companies, majorly for blot clots. Since July, $AZN has been consolidating around the resistance at $60.83. The price might drop in the coming weeks as some workers of companies might tender resignation because the vaccines are made mandatory, which deprives them of their human rights. Since May 2021, RSI has shown three indications of the price being overbought.